Faculty secures over $35m in NHMRC Ideas Grants
Researchers from Monash Medicine, Nursing and Health Sciences were awarded in excess of $35 million across 33 projects in the NHMRC Ideas Grant scheme.
Collectively, the University has received more than $41 million for 38 projects - the most of any Australian university for the second year in a row.
Federal Minister for Health and Aged Care the Hon Greg Hunt MP announced the grants last week as part of $239 million in funding for 248 research projects, which will help advance understanding of a wide range of health and medical issues faced by Australians.
The Ideas Grant scheme is designed to support innovative research projects addressing a specific question, and provide particular opportunities for early and mid-career researchers.
Monash projects to be awarded funding include improving therapeutic delivery of RNA, research into brain injury in intimate partner violence, a treatment for prostate cancer, the effects of early exposure to bushfires on adult brain structure and function, fertility treatment, and psychedelic treatment of anorexia nervosa.
Congratulations to all of our researchers who have secured funding in this scheme.
Monash Biomedicine Discovery Institute
- Professor Mibel Aguilar - Pathogenic membranes as therapeutic drug targets
- Professor Zane Andrews - Top down cortical control of hypothalamic feeding circuits
- Associate Professor Chen Davidovich - Rewriting the dogma of chromatin compaction: a new pathway for polycomb-mediated gene repression in development and disease
- Professor Katherine (Kate) Denton - Sex-differences in cellular aging and cardiovascular disease: Role of the AngIV/IRAP axis
- Dr Claire Foldi - Can psychedelics treat anorexia nervosa? Insights into the therapeutic effects of psilocybin in an animal model
- Associate Professor Craig Harrison - Transforming fertility treatment
- Associate Professor Tracy Heng - The mesenchymal stromal cell paradox – living cell therapy or dying therapeutic cell?
- Associate Professor Karla Hutt - Does Chlamydia infection damage the ovary and compromise fertility?
- Dr Mitchell Lawrence - ComBATing lethal prostate cancer with combination Bipolar Androgen Therapy
- Dr Sarah Lockie - Targeting the brain and sympathetic nervous system to improve outcomes in cancer cachexia
- Dr Farshad Mansouri - The effects of early exposure to bushfires on adult brain structure and function
- Professor Anthony Purcell - Dominant classes of tumour specific antigens in Melanoma
- Associate Professor Anna Roujeinikova Achieving benefit without harm: a next-generation glucocorticoid replacement
- - Elucidating the function of host-derived cysteine in bacterial virulence
- Professor Mike Ryan - Molecular mechanisms underlying the pathogenesis of complex I dysfunction and mitochondrial disease
- Professor Martin Stone - Defining chemotactic signalling networks to identify new anti-inflammatory targets
- Associate Professor Renea Taylor - Developing novel CAR T cell therapy approaches to treat prostate cancer
- Associate Professor Lee Wong - Chromatin defects in histone mutated brain cancers: from basic mechanisms to novel therapeutic strategies
Australian Regenerative Medicine Institute
- Associate Professor Jan Kaslin - Precursor neurons on standby fast track neural repair
- Associate Professor Edwina McGlinn - MicroRNA targeting to enhance haematopoietic stem cell function
School of Clinical Sciences at Monash Health
- Dr Sarah Jones - Achieving benefit without harm: a next-generation glucocorticoid replacement
- Professor Stuart Hooper - Improving respiratory support for preterm infants at birth
- Professor Richard Ferrero - Defining a protective role for NLRC5 signalling in Helicobacter pylori disease
- Dr Shalini Amukotuwa - Artificial Intelligence to Understand and Predict Chronic Subdural Haematoma Evolution
Central Clinical School
- Professor Patrick Kwan - Machine learning models for personalised epilepsy management
- Associate Professor Sandy Shultz - Brain injury in intimate partner violence: Insight into a silent pandemic
- Dr Sih Min Tan - Investigating complement C5a receptor 2 as a therapeutic target for diabetic kidney disease
- Dr Zhong-Lin Chai - New strategy to safely and effectively reduce diabetic kidney disease
- Professor Harshal Nandurkar - A novel single treatment for two serious complications of allogeneic stem cell transplantation: acute graft-versus-host disease and sinusoidal obstruction syndrome.
- Dr Mastura Monif - Glioblastoma - inhibition of P2X7R as a potential therapeutic target for treatment of this aggressive cancer.
Turner Institute for Brain and Mental Health
- Dr Laura Jobson - Building an Evidence-Base to inform Post-Traumatic Stress Disorder (PTSD) Treatment for Culturally and Linguistically Diverse Communities
- Professor Mark Bellgrove - Neuropharmacology of decision-making: causal brain network modelling across species
- Dr Bei Bei - Circadian clock, sleep, and depression in adolescence: Modelling a novel pathway
School of Public Health and Preventive Medicine
- Associate Professor Zanfina Ademi Delaney - A novel approach integrating genomics into the health economic modelling of therapeutics
The full list of recipients can be found here.
About Monash University
Monash University is Australia’s largest university with more than 80,000 students. In the 60 years since its foundation, it has developed a reputation for world-leading high-impact research, quality teaching, and inspiring innovation.
With four campuses in Australia and a presence in Malaysia, China, India, Indonesia and Italy, it is one of the most internationalised Australian universities.
As a leading international medical research university with the largest medical faculty in Australia and integration with leading Australian teaching hospitals, we consistently rank in the top 50 universities worldwide for clinical, pre-clinical and health sciences.
For more news, visit Medicine, Nursing and Health Sciences or Monash University.
MEDIA ENQUIRIES
E: media@monash.edu